Cite
HARVARD Citation
Dixon, B. et al. (2021). Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 9 (4), pp. 360-372. [Online].